Iranian Red Crescent Medical Journal

Published by: Kowsar

Cost-effectiveness of Methadone Maintenance Treatment in Prevention of HIV Among Drug Users in Shiraz, South of Iran

Ali Keshtkaran 1 , Alireza Mirahmadizadeh 2 , * , Alireza Heidari 3 and Mehdi Javanbakht 4
Authors Information
1 School of Management and Medical Information Sciences, Shiraz University of Medical Sciences, Shiraz, IR Iran
2 Shiraz AIDS Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
3 Health Management and Social Development Research Center, Golestan University of Medical Sciences, Gorgan, IR Iran
4
Article information
  • Iranian Red Crescent Medical Journal: January 5, 2014, 16 (1); e7801
  • Published Online: January 5, 2014
  • Article Type: Research Article
  • Received: September 17, 2012
  • Revised: February 20, 2013
  • Accepted: November 12, 2013
  • DOI: 10.5812/ircmj.7801

To Cite: Keshtkaran A, Mirahmadizadeh A, Heidari A, Javanbakht M. Cost-effectiveness of Methadone Maintenance Treatment in Prevention of HIV Among Drug Users in Shiraz, South of Iran, Iran Red Crescent Med J. 2014 ; 16(1):e7801. doi: 10.5812/ircmj.7801.

Abstract
Copyright © 2014, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Zareban A, Heidarnia A, Rakhshani F, Jabbari H, Abdollahi M. [Effect of AIDS education program on knowledge, attitude practice of sailors Chabahar port]. East Tabib. 2006; 8: 36-29
  • 2. Ebong RD. knowledge and attitudes of nurses toward AIDS: A case study of general hospital Ogoja, Cross river state, Nigeria. Inte Quart Commun Health Edu. 2003; 22(1): 131-141
  • 3. AIDS/HIV Surveillance Report (December 2004) 2004;
  • 4. Epidemiological Fact Sheets on HIV/AIDS and Sexually Transmitted Infections- Islamic Republic of Iran 2004;
  • 5. Barnett PG. Comparison of costs and utilization among buprenorphine and methadone patients. Addiction. 2009; 104(6): 982-92[DOI][PubMed]
  • 6. Magis-Rodriguez C, Brouwer KC, Morales S, Gayet C, Lozada R, Ortiz-Mondragon R, et al. HIV prevalence and correlates of receptive needle sharing among injection drug users in the Mexican-U.s. border city of Tijuana. J Psychoactive Drugs. 2005; 37(3): 333-9[PubMed]
  • 7. Des Jarlais DC, Casriel C, Friedman SR, Rosenblum A. AIDS and the transition to illicit drug injection--results of a randomized trial prevention program. Br J Addict. 1992; 87(3): 493-8[PubMed]
  • 8. Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009; (3)[DOI][PubMed]
  • 9. Barnett PG. The cost-effectiveness of methadone maintenance as a health care intervention. Addiction. 1999; 94(4): 479-88[PubMed]
  • 10. Barnett PG, Hui SS. The cost-effectiveness of methadone maintenance. Mt Sinai J Med. 2000; 67(5-6): 365-74[PubMed]
  • 11. Stark K, Muller R, Bienzle U, Guggenmoos-Holzmann I. Methadone maintenance treatment and HIV risk-taking behaviour among injecting drug users in Berlin. J Epidemiol Community Health. 1996; 50(5): 534-7[PubMed]
  • 12. Thiede H, Hagan H, Murrill CS. Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area. J Urban Health. 2000; 77(3): 331-45[PubMed]
  • 13. Wittchen HU, Apelt SM, Soyka M, Gastpar M, Backmund M, Golz J, et al. Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: a naturalistic study in 2694 patients. Drug Alcohol Depend. 2008; 95(3): 245-57[DOI][PubMed]
  • 14. Gossop M, Marsden J, Stewart D, Treacy S. Reduced injection risk and sexual risk behaviours after drug misuse treatment: results from the National Treatment Outcome Research Study. AIDS Care. 2002; 14(1): 77-93[DOI][PubMed]
  • 15. Bertrand JT, O'Reilly K, Denison J, Anhang R, Sweat M. Systematic review of the effectiveness of mass communication programs to change HIV/AIDS-related behaviors in developing countries. Health Educ Res. 2006; 21(4): 567-97[DOI][PubMed]
  • 16. Dolan KA, Shearer J, MacDonald M, Mattick RP, Hall W, Wodak AD. A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system. Drug Alcohol Depend. 2003; 72(1): 59-65[PubMed]
  • 17. Spire B, Lucas GM, Carrieri MP. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST). Int J Drug Policy. 2007; 18(4): 262-70[DOI][PubMed]
  • 18. Masaki E, Ravenga A, Wang S, Wilson D. Cost-Effectiveness of targeted intervention in Guangxi, China. 2011;
  • 19. Holtgrave DR, Pinkerton SD. Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. J Acquir Immune Defic Syndr Hum Retrovirol. 1997; 16(1): 54-62[PubMed]
  • 20. Donoghoe MC. Sex, HIV and the injecting drug user. Br J Addict. 1992; 87(3): 405-16[PubMed]
  • 21. Kumaranayake L, Vickerman P, Walker D, Samoshkin S, Romantzov V, Emelyanova Z, et al. The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, Belarus. Addiction. 2004; 99(12): 1565-76[DOI][PubMed]
  • 22. Costing Guideline for HIV prevention Strategies, Joint United Nations Programme on HIV/AIDS. 2000;
  • 23. Mozafarzadeh Sh, Vahdaninia M. [Health knowledge about AIDS in female high school students]. Monitoring J. 2008; 7: 180-173
  • 24. Weinstein MC, Graham JD, Siegel JE, Fineberg HV. AIDS, Sexual Behavior, and Intravenous Drug Use. 1989; : 471-499
  • 25. Hogan DR, Baltussen R, Hayashi C, Lauer JA, Salomon JA. Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries. BMJ. 2005; 331(7530): 1431-7[DOI][PubMed]
  • 26. Varghese B, Maher JE, Peterman TA, Branson BM, Steketee RW. Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis. 2002; 29(1): 38-43[PubMed]
  • 27. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 2006; 20(10): 1447-50[DOI][PubMed]
  • 28. Young TN, Arens FJ, Kennedy GE, Laurie JW, Rutherford Gw. Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure. Cochrane Database Syst Rev. 2007; (1)[DOI][PubMed]
  • 29. Duda SN, Cushman C, Masys DR. An XML model of an enhanced data dictionary to facilitate the exchange of pre-existing clinical research data in international studies. Stud Health Technol Inform. 2007; 129: 449-53[PubMed]
  • 30. Chakraborty H, Sen PK, Helms RW, Vernazza PL, Fiscus SA, Eron JJ, et al. Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS. 2001; 15(5): 621-7[PubMed]
  • 31. Wiley JA, Herschkorn SJ, Padian NS. Heterogeneity in the probability of HIV transmission per sexual contact: the case of male-to-female transmission in penile-vaginal intercourse. Stat Med. 1989; 8(1): 93-102[PubMed]
  • 32. Abdala N, Crowe M, Tolstov Y, Heimer R. Survival of human immunodeficiency virus type 1 after rinsing injection syringes with different cleaning solutions. Subst Use Misuse. 2004; 39(4): 581-600[PubMed]
  • 33. de Vincenzi I. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV. N Engl J Med. 1994; 331(6): 341-6[DOI][PubMed]
  • 34. Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, Wabwire-Mangen F, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet. 2001; 357(9263): 1149-53[DOI][PubMed]
  • 35. Pinkerton SD, Holtgrave DR, DiFranceisco W, Semaan S, Coyle SL, Johnson-Masotti AP. Cost-threshold analyses of the National AIDS Demonstration Research HIV prevention interventions. AIDS. 2000; 14(9): 1257-68[PubMed]
  • 36. Tuli K, Sansom S, Purcell DW, Metsch LR, Latkin CA, Gourevitch MN, et al. Economic evaluation of an HIV prevention intervention for seropositive injection drug users. J Public Health Manag Pract. 2005; 11(6): 508-15[PubMed]
  • 37. Boily MC, Baggaley RF, Wang L, Masse B, White RG, Hayes RJ, et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis. 2009; 9(2): 118-29[DOI][PubMed]
  • 38. Khattak MF, Salamat N, Bhatti FA, Qureshi TZ. Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan. J Pak Med Assoc. 2002; 52(9): 398-402[PubMed]
  • 39. Stramer SL, Glynn SA, Kleinman SH, Strong DM, Caglioti S, Wright DJ, et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med. 2004; 351(8): 760-8[DOI][PubMed]
  • 40. Wilson DP, Jin F, Jansson J, Zablotska I, Grulich AE. Infectiousness of HIV-infected men who have sex with men in the era of highly active antiretroviral therapy. AIDS. 2010; 24(15): 2420-1[DOI][PubMed]
  • 41. Hudgens MG, Longini IM, Jr, Vanichseni S, Hu DJ, Kitayaporn D, Mock PA, et al. Subtype-specific transmission probabilities for human immunodeficiency virus type 1 among injecting drug users in Bangkok, Thailand. Am J Epidemiol. 2002; 155(2): 159-68[PubMed]
  • 42. Baggaley RF, Boily MC, White RG, Alary M. Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis. AIDS. 2006; 20(6): 805-12[DOI][PubMed]
  • 43. Durantini MR, Albarracin D, Mitchell AL, Earl AN, Gillette JC. Conceptualizing the Influence of Social Agents of Behavior Change: A Meta-Analysis of the Effectiveness of HIV-Prevention Interventionists for Different Groups. Psychol Bull. 2006; 132(2): 212-48[DOI][PubMed]
  • 44. Frye V, Latka MH, Wu Y, Valverde EE, Knowlton AR, Knight KR, et al. Intimate partner violence perpetration against main female partners among HIV-positive male injection drug users. J Acquir Immune Defic Syndr. 2007; 46 Suppl 2-9[DOI][PubMed]
  • 45. Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev. 2002; (1)[DOI][PubMed]
  • 46. Minnis AM, Padian NS. Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: current evidence and future research directions. Sex Transm Infect. 2005; 81(3): 193-200[DOI][PubMed]
  • 47. Flynn N, Jain S, Keddie EM, Carlson JR, Jennings MB, Haverkos HW, et al. In vitro activity of readily available household materials against HIV-1: is bleach enough? J Acquir Immune Defic Syndr. 1994; 7(7): 747-53[PubMed]
  • 48. Afshar P. Personal Communication. 2003;
  • 49. Burrows D, Wodak A. Harm Reduction in Iran, Issues in national scale-up: Report for World Health Organization 2008;
  • 50. Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008; 372(9651): 1733-45[DOI][PubMed]
  • 51. Mirahmadzadeh A, Kadivar M, Ghane Shirazi R, Fararooyi M. [The frequency of infection from human immunodeficiency virus (HIV) in injecting drug users in Shiraz]. J Gorgan Uni Med Sci. 2001; 3: 42–39
  • 52. Clatts MC, Goldsamt L, Neaigus A, Welle DL. The social course of drug injection and sexual activity among YMSM and other high-risk youth: an agenda for future research. J Urban Health. 2003; 80(4 Suppl 3)-39[PubMed]
  • 53. Zaric GS, Barnett PG, Brandeau ML. HIV transmission and the cost-effectiveness of methadone maintenance. Am J Public Health. 2000; 90(7): 1100-11[PubMed]
  • 54. Bayoumi AM, Zaric GS. The cost-effectiveness of Vancouver's supervised injection facility. CMAJ. 2008; 179(11): 1143-51[DOI][PubMed]
  • 55. Macalino GE, Celentano DD, Latkin C, Strathdee SA, Vlahov D. Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Educ Prev. 2002; 14(5): 367-78[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments